Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report

BACKGROUND: Nivolumab is an immune checkpoint inhibitor (ICI) and is used for the treatment of advanced non-small cell lung cancer (NSCLC). Several immune-mediated neurological adverse events associated with ICIs have been reported to date, such as Guillain-Barré syndrome. Nivolumab-associated neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakoh, Takashi, Kanzaki, Mami, Miyamoto, Atsushi, Mochizuki, Sayaka, Kakumoto, Toshiyuki, Sato, Kenichiro, Uesaka, Yoshikazu, Kishi, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916037/
https://www.ncbi.nlm.nih.gov/pubmed/31842803
http://dx.doi.org/10.1186/s12885-019-6444-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916037/
https://www.ncbi.nlm.nih.gov/pubmed/31842803
http://dx.doi.org/10.1186/s12885-019-6444-0

Ejemplares similares